[Table/Fig-7]:

Gender wise response to treatment.

Gender		Male	Female	Total
Group A	Baseline	7.45±1.3	7.54±1.6	7.51±1.5
	three months	1.72±1.5	3.17±2.7	2.70±2.51
	CI at 95%	4.48-6.98	3.07-5.67	3.82-5.80
	p-value	<0.001	<0.001	<0.001
Group B	Baseline	7.25±1.8	7.14±1.3	7.22±1.7
	three months	1.58±1.1	0.85±0.8	1..41±1.0
	CI at 95%	4.80-6.54	5.03-7.55	5.10-6.52
	p-value	<0.001	<0.001	<0.001
Group C	Baseline	8.00±0.70	7.75±1.6	7.78±1.6
	three months	5.20±3.4	4.80±3.3	4.87±3.3
	CI at 95%	0.78-6.38	1.53-4.37	1.63-4.19
	p-value	<0.1089	<0.001	<0.001
Group D	Baseline	5.52±1.6	5.00±0.0	5.47±1.5
	three months	0.43±0.5	2*1	0.50±0.6
	CI at 95%	4.24-5.94	-	4.18-5.76
	p-value	<0.001	-	<0.001

¹As there was only one female at three months follow up in Group D, an average, standard deviation and p-value could not be calculated.